A Study of the Natural Progression of Interstitial Lung Disease (ILD)

Recruiting

• Conditions: Sarcoidosis; Interstitial Lung Diseases; Connective Tissue Disorder; Idiopathic Pulmonary Fibrosis

• Registration Number: NCT00470327
• Lead Sponsor: University of Chicago

Brief Summary

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09
• Study First Submitted: 2007-05-03
• Study First Submitted QC: 2007-05-04
• Study First Posted: 2007-05-07
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-09
• Last Update Posted: 2025-05-14
• Primary Completion: 2030-12
• Study Completion: 2030-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 4000

Inclusion Criteria

• Interstitial lung disease

Exclusion Criteria

• Does not have Interstitial lung disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Natural history of course of disease in patients with Interstitial lung disease (ILD)	Yearly	We assess mortality roughly yearly but duration is unlimited

Trial Locations

Locations (1)

University of Chicago; 🇺🇸 Chicago, Illinois, United States